CompletedNot applicableNCT00461799

Orlistat Treatment of Crigler-Najjar Disease

Studying Crigler-Najjar syndrome

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University Medical Center Groningen
Principal Investigator: Anja M. Hafkamp, MD
University Medical Center Groningen and Erasmus University Medical Center
Intervention: orlistat(drug)
Enrollment: 16 enrolled
Eligibility: 8 years · All sexes
Timeline: 2003 – 2004

Study locations (1)

Erasmus University Medical Center, Rotterdam, Netherlands

Collaborators

Erasmus Medical Center · De Najjar Stichting

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00461799 on ClinicalTrials.gov

Other trials for Crigler-Najjar syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT03466463
Gene Therapy for Severe Crigler Najjar Syndrome
Genethon

See all trials for Crigler-Najjar syndrome →

← Back to all trials